Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
US4938948A · kind A · utility
74Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 1985 |
| Grant date | Jul 3, 1990 |
| Priority date | — |
| Expiry date | Oct 11, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/861
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hybridomas producing monoclonal antibodies suitable for imaging and diagnosis of human breast tumors and such monoclonal antibodies are claimed. The monoclonals are characterized by breast tumor binding range, breast cancer cell line range, and selectivity. Immunoimaging agents comprising the monoclonal antibody and a detectable label, either directly or indirectly conjugated to the antibody are claimed. Methods for imaging breast tumors using the immunoimaging agents are described and claimed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.